Biotia is a startup based in the United States.
Biotia develops genomics-based diagnostic tools and platforms that detect and characterize pathogens. The company leverages metagenomics and AI to improve infectious disease diagnostics, support outbreak prediction, and enable global health monitoring.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.